TGF-β1-induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
Research output: Contribution to journal › Letter › Research › peer-review
Standard
TGF-β1-induced endothelial-mesenchymal transition : a potential contributor to fibrotic remodeling in atrial fibrillation? / Saljic, Arnela; Grandi, Eleonora; Dobrev, Dobromir.
In: The Journal of Clinical Investigation, Vol. 132, No. 13, e161070, 2022.Research output: Contribution to journal › Letter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - TGF-β1-induced endothelial-mesenchymal transition
T2 - a potential contributor to fibrotic remodeling in atrial fibrillation?
AU - Saljic, Arnela
AU - Grandi, Eleonora
AU - Dobrev, Dobromir
PY - 2022
Y1 - 2022
N2 - Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, with an unmet therapeutic need. Fibrotic remodeling, in which collagen-producing atrial fibroblasts play a crucial role, substantially contributes to arrhythmia promotion and progression. In this issue of the JCI, Lai, Tsai, and co-authors reveal that TGF-β1 promoted endothelial-mesenchymal transition during AF and put forward the notion that, in the adult heart, atrial fibroblasts can originate from different cellular sources. These important findings extend our understanding of the origin, biology, and function of fibroblasts and offer possibilities for therapeutic targeting of fibrosis in AF.
AB - Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, with an unmet therapeutic need. Fibrotic remodeling, in which collagen-producing atrial fibroblasts play a crucial role, substantially contributes to arrhythmia promotion and progression. In this issue of the JCI, Lai, Tsai, and co-authors reveal that TGF-β1 promoted endothelial-mesenchymal transition during AF and put forward the notion that, in the adult heart, atrial fibroblasts can originate from different cellular sources. These important findings extend our understanding of the origin, biology, and function of fibroblasts and offer possibilities for therapeutic targeting of fibrosis in AF.
KW - EXTRACELLULAR-MATRIX
KW - CARDIAC FIBROBLAST
KW - DISEASE
U2 - 10.1172/JCI161070
DO - 10.1172/JCI161070
M3 - Letter
C2 - 35775488
AN - SCOPUS:85133289594
VL - 132
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
SN - 0021-9738
IS - 13
M1 - e161070
ER -
ID: 313883514